This site is intended for health professionals only

Published on 8 December 2011

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

Interferon-b: first-line therapy in multiple sclerosis

teaser

Per Soelberg Sorensen

Danish Multiple Sclerosis Centre,

University of Copenhagen and Department of Neurology, Rigshospitalet, Copenhagen, Denmark

Approximately 85% of patients with multiple sclerosis (MS) have a relapsing



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
E-Health cloud to give NHS patients control over data
New England Journal of Medicine publishes nusinersen Phase III CHERISH study results
Pfizer drops to second in big pharma league table
Bivalirudin in coronary angioplasty procedures
Gene therapy: its place in disease management
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x